½ÃÀ庸°í¼­
»óǰÄÚµå
1604553

µð¸ÞÆ¿Æ÷¸§¾Æ¹Ìµå ½ÃÀå : ¿¹Ãø(2025-2030³â)

Dimethylformamide Market - Forecasts from 2025 to 2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Knowledge Sourcing Intelligence | ÆäÀÌÁö Á¤º¸: ¿µ¹® 145 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

µð¸ÞÆ¿Æ÷¸§¾Æ¹Ìµå ½ÃÀåÀÇ CAGRÀº 4.53%À̸ç, ½ÃÀå ±Ô¸ð´Â 2025³â 28¾ï 7,000¸¸ ´Þ·¯¿¡¼­ 2030³â 35¾ï 9,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

µð¸ÞÆ¿Æ÷¸§¾Æ¹Ìµå(DMF) ½ÃÀåÀº ´ÙÀç´Ù´ÉÇÑ È­ÇÐÀû Ư¼ºÀ¸·Î ÀÎÇØ ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, DMF´Â È­ÇÐ »ê¾÷¿¡¼­ ¿ë¸Å·Î »ç¿ëµÇ¸ç ÀǾàǰ, È­ÇÐÁ¦Ç°, ÇÃ¶ó½ºÆ½, ¼¶À¯Á¦Ç°¿¡ Àû¿ëµÇ°í ÀÖ½À´Ï´Ù. ÀǾàǰ ¹× È­ÇÐÁ¦Ç° Á¦Á¶ °øÁ¤¿¡¼­ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó DMFÀÇ »ç¿ëÀº Çʼö ºÒ°¡°áÇÑ ¿ä¼Ò·Î ÀÚ¸® Àâ¾Ò½À´Ï´Ù.

  • 2023³â 5¿ù, Inner Mongolia Qinghua Group Wustai Energy Chemical Co., Ltd.ÀÇ ¿¬°£ »ý»ê·® 10¸¸ ÅæÀÇ N, N-µð¸ÞÆ¿Æ÷¸§¾Æ¹Ìµå ÇÁ·ÎÁ§Æ®°¡ ¿Ï°øµÇ¾ú½À´Ï´Ù. ÀÌ ÇÁ·ÎÁ§Æ®´Â µð¸ÞÆ¿¾Æ¹Î°ú ÀÏ»êȭź¼Ò¸¦ ¿ø·á·Î ÇÏ°í ³ªÆ®·ý ¸ÞÅå»çÀ̵带 Ã˸ŷΠÇÏ¿© µð¸ÞÆ¿Æ÷¸§¾Æ¹Ìµå¸¦ ÇÕ¼ºÇÕ´Ï´Ù. ÀÌ ÇÁ·ÎÁ§Æ®ÀÇ ÃÑ ÅõÀÚ¾×Àº ¾à 1¾ï 6,541¸¸ 8,100À§¾ÈÀÔ´Ï´Ù. ¿¬Æò±Õ ¸ÅÃâ¾×Àº 9¾ï 7,893¸¸ 8,100À§¾È¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ·¯ÇÑ ´ë±Ô¸ð ÅõÀÚ´Â µð¸ÞÆ¿Æ÷¸§¾Æ¹ÌµåÀÇ Àüü »ý»ê´É·ÂÀ» È®´ëÇÒ °¡´É¼ºÀÌ ³ô½À´Ï´Ù.

µð¸ÞÆ¿Æ÷¸§¾Æ¹Ìµå ½ÃÀåÀÇ ÃËÁø¿äÀÎ

  • Á¦¾à ºÎ¹®ÀÇ ¼ö¿ä Áõ°¡

N,N-µð¸ÞÆ¿Æ÷¸§¾Æ¹Ìµå´Â Æú¸®¿ì·¹Åº ¼ÒÀç¿Í ¾ÆÅ©¸± ¼¶À¯¸¦ Ãë±ÞÇÏ´Â °øÀå¿¡¼­ »ç¿ëµÇ´Â ´ëÇ¥ÀûÀÎ ¿ë¸ÅÀ̸ç, DMF´Â Á¦¾à »ê¾÷¿¡¼­µµ Ȱ¿ëµÇ°í ÀÖ½À´Ï´Ù. ¼¼°èº¸°Ç±â±¸(WHO)¿¡ µû¸£¸é ºñ°¨¿°¼º Áúȯ(NCDs)À¸·Î ÀÎÇØ ¸Å³â 4,100¸¸ ¸íÀÌ »ç¸ÁÇϰí ÀÖ½À´Ï´Ù. ÀÌ ¹®Á¦´Â ´ë±â¿À¿°°ú °°Àº ȯ°æÀû À§Çè¿äÀÎÀÇ Áõ°¡, »ýȰ½À°üÀÇ º¯È­, ´ã¹è¿Í ¾ËÄÚ¿Ã »ç¿ëÀÇ Áõ°¡·Î ÀÎÇØ ´õ¿í ½É°¢ÇØÁö°í ÀÖ½À´Ï´Ù. ¿¬·É, Áö¿ª, Àα¸Åë°èÇÐÀû Ư¼º¿¡ °ü°è¾øÀÌ °ÅÀÇ ¸ðµç »ç¶÷µéÀÌ ºñ°¨¿°¼º Áúȯ(NCDs)ÀÇ ¿µÇâÀ» ¹Þ°í ÀÖ½À´Ï´Ù. ±× °á°ú, ÀǾàǰ ¹× ÀÇ·á±â±â ±¸¸Å¸¦ À§ÇÑ ÀÇ·áºñ ÁöÃâÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

OECD µ¥ÀÌÅͺ£À̽º¿¡ µû¸£¸é ÀÌÅ»¸®¾ÆÀÇ ÀǾàǰ ¸ÅÃâÀº 2021³â¿¡¼­ 2022³â±îÁö 9.27% Áõ°¡ÇßÀ¸¸ç, º§±â¿¡ÀÇ Áõ°¡À²Àº 15.12%, ·è¼ÀºÎ¸£Å©ÀÇ Áõ°¡À²Àº 8.74%, ½ºÆäÀÎÀÇ Áõ°¡À²Àº 9.30%, ½º¿þµ§ÀÇ Áõ°¡À²Àº 25.11%, ½ºÀ§½ºÀÇ Áõ°¡À²Àº 10.37%ÀÔ´Ï´Ù. ÀÌ ¼öÄ¡´Â ´Ù¾çÇÑ ½ÅüÀû, Á¤½ÅÀû ÁúȯÀ» ¾Î°í ÀÖ´Â ½Ã¹ÎµéÀÇ »î¿¡¼­ ÀǾàǰÀÇ Çʿ伺ÀÌ Áõ°¡Çϰí ÀÖÀ½À» ½Ã»çÇÕ´Ï´Ù. µû¶ó¼­ ÀǾàǰ¿¡ ´ëÇÑ DMFÀÇ ¼ö¿ä´Â ¿¹Ãø ±â°£ µ¿¾È Áõ°¡ÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

µð¸ÞÆ¿Æ÷¸§¾Æ¹Ìµå ½ÃÀåÀÇ Áö¸®Àû Àü¸Á

  • µð¸ÞÆ¿Æ÷¸§¾Æ¹Ìµå ½ÃÀåÀº Àü ¼¼°è 5°³ Áö¿ªÀ¸·Î ³ª´¹´Ï´Ù.

Áö¿ªº°·Î µð¸ÞÆ¿Æ÷¸§¾Æ¹Ìµå ½ÃÀåÀº ºÏ¹Ì, ³²¹Ì, À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«, ¾Æ½Ã¾ÆÅÂÆò¾çÀ¸·Î ±¸ºÐµË´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾çÀº Áß±¹, ÀϺ», Àεµ, Çѱ¹ µî ÁÖ¿ä °æÁ¦±¹ÀÌ ÁÖµµÇϰí ÀÖ½À´Ï´Ù. ¾Æ¼¼¾È ±¹°¡¿Í °°ÀÌ ±Þ¼ºÀåÇÏ´Â ½ÅÈï±¹ Áß ÀϺδ ÀÌ Áö¿ª¿¡ ¼ÓÇÕ´Ï´Ù.

¾Æ½Ã¾ÆÅÂÆò¾çÀº ÇÕ¼º ¼¶À¯ ¹× ¼¶À¯ÀÇ »ç¿ëÀÌ Áõ°¡ÇÔ¿¡ µû¶ó µð¸ÞÆ¿Æ÷¸§¾Æ¹Ìµå ½ÃÀå¿¡¼­ °¡Àå ºü¸¥ ¼ºÀåÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ºÏ¹Ì´Â Á¦¾à ¹× È­ÇÐ »ê¾÷¿¡¼­ ÁÖ·Î »ç¿ëµÇ¸é¼­ µð¸ÞÆ¿Æ÷¸§¾Æ¹Ìµå ½ÃÀå¿¡¼­ Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÀÌ º¸°í¼­¸¦ ±¸ÀÔÇØ¾ß ÇÏ´Â ÀÌÀ¯:

  • ÅëÂû·Â ÀÖ´Â ºÐ¼® : °í°´ ºÎ¹®, Á¤ºÎ Á¤Ã¥ ¹× »çȸ°æÁ¦Àû ¿äÀÎ, ¼ÒºñÀÚ ¼±È£µµ, »ê¾÷º°, ±âŸ ÇÏÀ§ ºÎ¹®¿¡ ÃÊÁ¡À» ¸ÂÃç ÁÖ¿ä Áö¿ª»Ó¸¸ ¾Æ´Ï¶ó ½ÅÈï Áö¿ª±îÁö Æ÷°ýÇÏ´Â »ó¼¼ÇÑ ½ÃÀå ÀλçÀÌÆ®¸¦ ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.
  • °æÀï »óȲ : ¼¼°è ÁÖ¿ä ±â¾÷µéÀÌ Ã¤ÅÃÇϰí ÀÖ´Â Àü·«Àû Àü·«À» ÀÌÇØÇϰí, ¿Ã¹Ù¸¥ Àü·«À¸·Î ½ÃÀå ħÅõ °¡´É¼ºÀ» ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù.
  • ½ÃÀå ÃËÁø¿äÀΰú ¹Ì·¡ µ¿Çâ : ¿ªµ¿ÀûÀÎ ¿äÀΰú ¸Å¿ì Áß¿äÇÑ ½ÃÀå µ¿Çâ, ±×¸®°í À̵éÀÌ ÇâÈÄ ½ÃÀå ¹ßÀüÀ» ¾î¶»°Ô Çü¼ºÇÒ °ÍÀÎÁö¿¡ ´ëÇØ ¾Ë¾Æº¾´Ï´Ù.
  • Çൿ °¡´ÉÇÑ Á¦¾È : ¿ªµ¿ÀûÀΠȯ°æ ¼Ó¿¡¼­ »õ·Î¿î ºñÁî´Ï½º ½ºÆ®¸²°ú ¼öÀÍÀ» ¹ß±¼Çϱâ À§ÇÑ Àü·«Àû ÀÇ»ç°áÁ¤¿¡ ÀλçÀÌÆ®¸¦ Ȱ¿ëÇÕ´Ï´Ù.
  • ´Ù¾çÇÑ »ç¿ëÀÚ¿¡ ´ëÀÀ : ½ºÅ¸Æ®¾÷, ¿¬±¸±â°ü, ÄÁ¼³ÅÏÆ®, Áß¼Ò±â¾÷, ´ë±â¾÷¿¡ À¯ÀÍÇÏ°í ºñ¿ë È¿À²ÀûÀÔ´Ï´Ù.

¾î¶² ¿ëµµ·Î »ç¿ëµÇ´Â°¡?

»ê¾÷ ¹× ½ÃÀå ÀλçÀÌÆ®, »ç¾÷ ±âȸ Æò°¡, Á¦Ç° ¼ö¿ä ¿¹Ãø, ½ÃÀå ÁøÀÔ Àü·«, Áö¸®Àû È®Àå, ¼³ºñ ÅõÀÚ °áÁ¤, ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ© ¹× ¿µÇâ, ½ÅÁ¦Ç° °³¹ß, °æÀïÀÇ ¿µÇâ

Á¶»ç ¹üÀ§

  • 2022³âºÎÅÍ 2030³â±îÁöÀÇ °ú°Å µ¥ÀÌÅÍ ¹× Àü¸Á
  • ¼ºÀå ±âȸ, µµÀü °úÁ¦, °ø±Þ¸Á Àü¸Á, ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©, °í°´ Çൿ ¹× Æ®·»µå ºÐ¼®
  • °æÀï»ç Æ÷Áö¼Å´×, Àü·« ¹× ½ÃÀå Á¡À¯À² ºÐ¼®
  • ¸ÅÃâ ¼ºÀå ¹× ¿¹Ãø ±¹°¡¸¦ Æ÷ÇÔÇÑ ºÎ¹® ¹× Áö¿ª Æò°¡
  • ±â¾÷ ÇÁ·ÎÆÄÀϸµ(Àü·«, Á¦Ç°, À繫 »óÅÂ, ÁÖ¿ä ¹ßÀü µî)

µð¸ÞÆ¿Æ÷¸§¾Æ¹Ìµå ½ÃÀåÀº ´ÙÀ½°ú °°Àº ºÎ¹®À¸·Î ºÐ¼®µË´Ï´Ù.

¿ëµµº°

  • ¿ë¸Å
  • Ã˸Å
  • ¿ø·á

ÃÖÁ¾»ç¿ëÀÚ »ê¾÷º°

  • È­ÇÐó¸®
  • ÀǾàǰ
  • ¼¶À¯
  • ÆäÀÎÆ® ¹× ÄÚÆÃ
  • ¼¶À¯
  • ±âŸ

Áö¿ªº°

  • ºÏ¹Ì
  • ¹Ì±¹
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ³²¹Ì
  • ºê¶óÁú
  • ¾Æ¸£ÇîÆ¼³ª
  • ±âŸ ³²¹Ì
  • À¯·´
  • ¿µ±¹
  • µ¶ÀÏ
  • ÇÁ¶û½º
  • ÀÌÅ»¸®¾Æ
  • ½ºÆäÀÎ
  • ±âŸ ³²¹Ì
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • UAE
  • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
  • Áß±¹
  • Àεµ
  • ÀϺ»
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • Àεµ³×½Ã¾Æ
  • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç

¸ñÂ÷

Á¦1Àå ¼Ò°³

  • ½ÃÀå °³¿ä
  • ½ÃÀå Á¤ÀÇ
  • Á¶»ç ¹üÀ§
  • ½ÃÀå ¼¼ºÐÈ­
  • ÅëÈ­
  • °¡Á¤
  • ±âÁØ ¿¬µµ¿Í ¿¹Ãø ¿¬µµ ŸÀÓ¶óÀÎ
  • ÀÌÇØ°ü°èÀÚ¿¡ ´ëÇÑ ÁÖ¿ä ÀÌÁ¡

Á¦2Àå Á¶»ç ¹æ¹ý

  • Á¶»ç ¼³°è
  • Á¶»ç °úÁ¤

Á¦3Àå ÁÖ¿ä ¿ä¾à

  • ÁÖ¿ä Á¶»ç °á°ú
  • ¾Ö³Î¸®½ºÆ®ÀÇ °ßÇØ

Á¦4Àå ½ÃÀå ¿ªÇÐ

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • Á¦¾à ¾÷°è·ÎºÎÅÍÀÇ ¼ö¿ä Áõ°¡
    • ¿ëÁ¦·Î¼­ÀÇ »ê¾÷ ¿ëµµ Áõ°¡
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • °Ç°­ °ü·Ã À§Ç輺°ú ±âŸ ´ëüǰÀÇ ÀÔ¼ö °¡´É¼º
  • Porter's Five Forces ºÐ¼®
  • ¾÷°è ¹ë·ùüÀÎ ºÐ¼®

Á¦5Àå µð¸ÞÆ¿Æ÷¸§¾Æ¹Ìµå ½ÃÀå : ¿ëµµº°

  • ¼Ò°³
  • ¿ë¸Å
  • Ã˸Å
  • ¿ø·á

Á¦6Àå µð¸ÞÆ¿Æ÷¸§¾Æ¹Ìµå ½ÃÀå : ÃÖÁ¾ ÀÌ¿ë »ê¾÷º°

  • ¼Ò°³
  • È­ÇÐó¸®
  • ÀǾàǰ
  • ¼¶À¯
  • ÆäÀÎÆ® ¹× ÄÚÆÃ
  • ¼¶À¯
  • ±âŸ

Á¦7Àå µð¸ÞÆ¿Æ÷¸§¾Æ¹Ìµå ½ÃÀå : Áö¿ªº°

  • ¼¼°è °³¿ä
  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • ³²¹Ì
    • ºê¶óÁú
    • ¾Æ¸£ÇîÆ¼³ª
    • ±âŸ ³²¹Ì
  • À¯·´
    • ¿µ±¹
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • ±âŸ À¯·´
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • Çѱ¹
    • ´ë¸¸
    • ű¹
    • Àεµ³×½Ã¾Æ
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç

Á¦8Àå °æÀï ȯ°æ°ú ºÐ¼®

  • ÁÖ¿ä ±â¾÷°ú Àü·« ºÐ¼®
  • ½ÃÀå Á¡À¯À² ºÐ¼®
  • ÇÕº´, Àμö, ÇÕÀÇ, Çù¾÷
  • °æÀï ´ë½Ãº¸µå

Á¦9Àå ±â¾÷ °³¿ä

  • BASF SE
  • Balaji Amines
  • Belle Chemical
  • Chemanol
  • Eastman Chemical Company
  • Jiutian Chemical Group Ltd
  • Mitsubishi Gas Chemical Company Inc.
  • Pon Pure Chemicals Group
  • Shandong Hualu-Hengsheng Chemical Co., Ltd.
ksm 24.12.16

The dimethylformamide market is valued at a CAGR of 4.53%, reaching a market size of US$3.59 billion in 2030 from US$2.87 billion in 2025.

The dimethylformamide (DMF) market would witness growth due to its chemical properties such as its versatility. It is used as a solvent in the chemical industry, and DMF finds application in pharmaceuticals, chemicals, plastics, and textiles. With the growing demand for pharmaceutical and chemical production processes, the utilization of DMF has been vital.

  • In May 2023, the project of Inner Mongolia Qinghua Group Wustai Energy Chemical Co., Ltd. was completed for the 100,000 tons/year N, N-dimethylformamide. The project uses dimethylamine and carbon monoxide as raw materials and sodium methoxide as catalysts to synthesize dimethylformamide. It had a total investment in the project of about 165.4181 million yuan. It was expected to achieve an average annual sales revenue of 978.9381 million yuan. Such significant investment would likely expand the overall production capacity of the dimethylformamide.

Dimethylformamide market drivers

  • Growing demand from the pharmaceutical sector

N, N-Dimethylformamide is a representative solvent used in factories handling polyurethane materials and acrylic fibers. DMF is also utilized in the pharmaceutical industry. According to the World Health Organization, noncommunicable diseases (NCDs) result in the deaths of 41 million people each year. This challenge is rising due to increasing environmental risk factors such as air pollution, changing lifestyles, and the growing use of tobacco and alcohol. Almost all people of ages, regions, and demographics are affected by noncommunicable diseases (NCDs). This resulted in increased healthcare spending for the purchase of pharmaceuticals and medical devices.

The pharmaceutical sales of many major European Union countries are showing an increase such as Italy's pharmaceutical sales have risen by 9.27% from 2021 to 2022, similarly for Belgium's increase was 15.12%, Luxembourg's 8.74%, Spain's 9.30%, Sweden's staggering increase of 25.11%, and Switzerland's 10.37%, according to OECD database. The number suggests the growing need for pharmaceuticals in the lives of citizens with various physical and mental ailments. Thus, demand for the DMF in pharmaceuticals would increase during the forecast period.

Dimethylformamide market geographical outlook

  • The dimethylformamide market is segmented into five regions worldwide

By geography, the dimethylformamide market is segmented into North America, South America, Europe, the Middle East and Africa, and Asia Pacific. The major economies like China, Japan, India, and South Korea dominate the Asia-Pacific region. Some of the fastest-growing emerging economies are from this region, such as ASEAN countries.

The Asia Pacific region is expected to see the fastest growth in the dimethylformamide market due to increasing applications in synthetic fibers and textiles.

North America is expected to have a significant market share in the dimethylformamide market due to its major utilization in the pharmaceutical and chemical industries.

Reasons for buying this report:-

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, other sub- segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape up future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decision to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data & forecasts from 2022 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, Customer Behaviour, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others)

The dimethylformamide market is analyzed into the following segments:

By Application

  • Solvent
  • Catalyst
  • Raw Material

By End User Industry

  • Chemical Processing
  • Pharmaceuticals
  • Textiles
  • Paints & Coating
  • Textile
  • Others

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Rest of South America
  • Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Spain
  • Rest of Europe
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Rest of the Middle East and Africa
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Taiwan
  • Thailand
  • Indonesia
  • Rest of Asia-Pacific

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base and Forecast Years Timeline
  • 1.8. Key benefits for the stakeholders

2. RESEARCH METHODOLOGY

  • 2.1. Research Design
  • 2.2. Research Process

3. EXECUTIVE SUMMARY

  • 3.1. Key Findings
  • 3.2. Analyst View

4. MARKET DYNAMICS

  • 4.1. Market Drivers
    • 4.1.1. Growing demand from the pharmaceutical sector
    • 4.1.2. Increasing industrial applications as a solvent
  • 4.2. Market Restraints
    • 4.2.1. Health-related hazards and availability of other substitutes
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. The Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis

5. DIMETHYLFORMAMIDE MARKET BY APPLICATION

  • 5.1. Introduction
  • 5.2. Solvent
  • 5.3. Catalyst
  • 5.4. Raw Material

6. DIMETHYLFORMAMIDE MARKET BY END-USER INDUSTRY

  • 6.1. Introduction
  • 6.2. Chemical Processing
  • 6.3. Pharmaceuticals
  • 6.4. Textiles
  • 6.5. Paints & Coating
  • 6.6. Textile
  • 6.7. Others

7. DIMETHYLFORMAMIDE MARKET BY GEOGRAPHY

  • 7.1. Global Overview
  • 7.2. North America
    • 7.2.1. United States
    • 7.2.2. Canada
    • 7.2.3. Mexico
  • 7.3. South America
    • 7.3.1. Brazil
    • 7.3.2. Argentina
    • 7.3.3. Rest of South America
  • 7.4. Europe
    • 7.4.1. United Kingdom
    • 7.4.2. Germany
    • 7.4.3. France
    • 7.4.4. Italy
    • 7.4.5. Spain
    • 7.4.6. Rest of Europe
  • 7.5. Middle East and Africa
    • 7.5.1. Saudi Arabia
    • 7.5.2. United Arab Emirates
    • 7.5.3. Rest of the Middle East and Africa
  • 7.6. Asia-Pacific
    • 7.6.1. China
    • 7.6.2. India
    • 7.6.3. Japan
    • 7.6.4. South Korea
    • 7.6.5. Taiwan
    • 7.6.6. Thailand
    • 7.6.7. Indonesia
    • 7.6.8. Rest of Asia-Pacific

8. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 8.1. Major Players and Strategy Analysis
  • 8.2. Market Share Analysis
  • 8.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 8.4. Competitive Dashboard

9. COMPANY PROFILES

  • 9.1. BASF SE
  • 9.2. Balaji Amines
  • 9.3. Belle Chemical
  • 9.4. Chemanol
  • 9.5. Eastman Chemical Company
  • 9.6. Jiutian Chemical Group Ltd
  • 9.7. Mitsubishi Gas Chemical Company Inc.
  • 9.8. Pon Pure Chemicals Group
  • 9.9. Shandong Hualu-Hengsheng Chemical Co., Ltd.
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦